COVID-19: Latest Updates
Notice: 
Hurricane Fiona: Latest UpdatesCOVID-19: Latest UpdatesHurricane Fiona: Latest Updates
_0.png)
For immediate release – August 23, 2022
Research out of IWK Health is investigating the impact cancer treatment has on the microbiome of pediatric oncology patients. The study draws on an array of medical expertise and statistics to examine the effect antibiotics and antifungals have on this vulnerable population.
Continue ReadingWe are pleased to announce that Dr. Frank MacMaster will be joining IWK Health as the new vice president, Research & Innovation. He will also be appointed as a professor of psychiatry in the faculty of medicine at Dalhousie University. We look forward to welcoming MacMaster on September 5, 2022.
Continue ReadingFor immediate release – September 2, 2021
Halifax -IWK Health is reporting the first use of high dose ibuprofen in North America to treat patent ductus arteriosus (PDA) a common heart problem which occurs most often in extremely premature infants. In a paper published in the Journal of Perinatology the treatment shows a 21 per cent reduction in the need for the risky heart surgery.
Continue Reading
IWK Health is respected for its world-class research into disorders and diseases affecting women, children, youth and families and is home to many leading research centres.
Learn more about our research centres by visiting one of the links below.
Book Online